XML 89 R24.htm IDEA: XBRL DOCUMENT
v3.22.4

CAPITAL STOCK | 12 Months Ended
--- | ---
Dec. 31, 2022
Equity [Abstract] |
CAPITAL STOCK | REDEEMABLE NONCONTROLLING INTEREST — ALTUS Preferred Units Issuance On June 12, 2019, Altus Midstream LP issued and sold Preferred Units for an aggregate issue price of $625 million in a private offering exempt from the registration requirements of the Securities Act (the Closing). Altus Midstream LP received approximately $611 million in cash proceeds from the sale after deducting transaction costs and discounts to certain purchasers. Classification Prior to the deconsolidation of Altus on February 22, 2022, at December 31, 2021, the carrying amount of the Preferred Units was recorded as “Redeemable Noncontrolling Interest — Altus Preferred Unit Limited Partners” and classified as temporary equity on the Company’s consolidated balance sheet based on the terms of the Preferred Units, including the redemption rights with respect thereto. Measurement Altus applied a two-step approach to subsequent measurement of the redeemable noncontrolling interest related to the Preferred Units by first allocating a portion of the net income of Altus Midstream LP in accordance with the terms of the partnership agreement. An additional adjustment to the carrying value of the Preferred Unit redeemable noncontrolling interest at each period end was recorded, if applicable. The amount of such adjustment was determined based upon the accreted value method to reflect the passage of time until the Preferred Units were exchangeable at the option of the holder. Pursuant to this method, the net transaction price was accreted using the effective interest method to the Redemption Price calculated at the seventh anniversary of the Closing. The total adjustment was limited to an amount such that the carrying amount of the Preferred Unit redeemable noncontrolling interest at each period end was equal to the greater of (a) the sum of (i) the carrying amount of the Preferred Units, plus (ii) the fair value of the embedded derivative liability and (b) the accreted value of the net transaction price. Activity related to the Preferred Units for the 2022 and 2021 periods is as follows:
|  | Units Outstanding |  | Financial Position(1) |
|  | (In millions, except unit data) |
Redeemable noncontrolling interest — Altus Preferred Unit limited partners: at December 31, 2020 |  | 660,694 |  |  | $ | 608 |  |
Cash distributions to Altus Preferred Unit limited partners |  | — |  |  | (46) |  |
Distributions payable to Altus Preferred Unit limited partners |  | — |  |  | (12) |  |
Allocation of Altus Midstream net income |  | N/A |  | 80 |  |
Accreted value adjustment |  | N/A |  | 82 |  |
Redeemable noncontrolling interest — Altus Preferred Unit limited partners: at December 31, 2021 |  | 660,694 |  |  | 712 |  |
Allocation of Altus Midstream LP net income |  | N/A |  | 12 |  |
Accreted value adjustment(1) |  | N/A |  | (82) |  |
Redeemable noncontrolling interest — Altus Preferred Unit limited partners: at February 22, 2022 |  | 660,694 |  |  | 642 |  |
Preferred Units embedded derivative |  |  |  | 89 |  |
Deconsolidation of Altus |  |  |  | (731) |  |
|  |  |  | $ | — |  |
(1) Includes the reversal of previously recorded accreted value adjustments due to the deconsolidation of Altus. N/A - not applicable. CAPITAL STOCK Common Stock Outstanding The following table provides changes to the Company’s common shares outstanding for the years ended December 31, 2022, 2021, and 2020:
|  | For the Year Ended December 31,
|  | 2022 |  | 2021 |  | 2020
Balance, beginning of year |  | 346,930,765 |  |  | 377,482,630 |  |  | 376,062,670 |
Shares issued for stock-based compensation plans: |  |  |  |  |  |
Treasury shares issued |  | 1,996 |  |  | 3,133 |  |  | 17,448 |
Common shares issued |  | 791,381 |  |  | 649,231 |  |  | 1,402,512 |
Treasury shares acquired |  | (36,164,993) |  |  | (31,204,229) |  |  | — |
Balance, end of year |  | 311,559,149 |  |  | 346,930,765 |  |  | 377,482,630 |
Net Income (Loss) per Common Share The following table provides a reconciliation of the components of basic and diluted net income (loss) per common share for the years ended December 31, 2022, 2021, and 2020:
|  | 2022 |  | 2021 |  | 2020
|  | Income |  | Shares |  | Per Share |  | Income |  | Shares |  | Per Share |  | Loss |  | Shares |  | Per Share
|  | (In millions, except per share amounts)
Basic: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income (loss) attributable to common stock |  | $ | 3,674 |  |  | 332 |  |  | $ | 11.05 |  |  | $ | 973 |  |  | 374 |  |  | $ | 2.60 |  |  | $ | (4,860) |  |  | 378 |  |  | $ | (12.86) |
Effect of Dilutive Securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options and other |  | $ | — |  |  | 1 |  |  | $ | (0.03) |  |  | $ | — |  |  | 1 |  |  | $ | (0.01) |  |  | $ | — |  |  | — |  |  | $ | — |
Diluted: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income (loss) attributable to common stock |  | $ | 3,674 |  |  | 333 |  |  | $ | 11.02 |  |  | $ | 973 |  |  | 375 |  |  | $ | 2.59 |  |  | $ | (4,860) |  |  | 378 |  |  | $ | (12.86) |
The diluted EPS calculation excludes options and restricted shares that were anti-dilutive totaling 2.4 million, 3.3 million, and 4.5 million for the years ended December 31, 2022, 2021, and 2020, respectively. Prior to the deconsolidation of Altus on February 22, 2022, the impact to net income (loss) attributable to common stock on an assumed conversion of the redeemable noncontrolling Preferred Units interest in Altus Midstream LP was anti-dilutive for the years ended December 31, 2021 and 2020. Stock Repurchase Program During 2018, the Company’s Board of Directors authorized the purchase of up to 40 million shares of the Company’s common stock. No shares were purchased under this authorization through December 31, 2020. During 2021, the Company’s Board of Directors authorized the purchase of an additional 40 million shares of the Company’s common stock. During the third quarter of 2022, the Company's Board of Directors further authorized the purchase of an additional 40 million shares of the Company's common stock. Shares may be purchased either in the open market or through privately held negotiated transactions. During 2021, the Company repurchased 31.2 million shares at an average price of $27.14 per share. During 2022, the Company repurchased 36.2 million shares at an average price of $39.34 per share, and as of December 31, 2022, the Company had remaining authorization to repurchase 52.6 million shares. The Company is not obligated to acquire any additional shares. Common Stock Dividend In the first quarter of 2020, the Company’s Board of Directors approved a reduction in the Company’s quarterly dividends from $0.25 per share to $0.025 per share, effective for all dividends payable after March 12, 2020. During the third quarter of 2021, the Company’s Board of Directors approved an increase in its quarterly dividend from $0.025 per share to $0.0625 per share, and in the fourth quarter of 2021, approved a further increase in its quarterly dividend to $0.125 per share. During the third quarter of 2022, the Company’s Board of Directors approved another increase to its quarterly dividend to $0.25 per share. For the years ended December 31, 2022, 2021, and 2020, the Company declared common stock dividends totaling $0.75 per share, $0.2375 per share, and $0.10 per share, respectively. Stock Compensation Plans The Company maintains several stock-based compensation plans, which include stock options, restricted stock, and conditional restricted stock unit plans. In 2021, pursuant to the Holding Company Reorganization, Apache’s outstanding common shares were converted into equivalent corresponding shares of APA. APA assumed sponsorship of all stock compensation plans. All cash-settled awards previously indexed to Apache’s stock price were subsequently indexed to APA’s stock price, and all unvested stock-settled awards will be settled in APA stock upon vesting. On May 12, 2016, the Company’s shareholders approved the 2016 Omnibus Compensation Plan (the 2016 Plan), which is used to provide eligible employees with equity-based incentives by granting incentive stock options, non-qualified stock options, performance awards, restricted stock awards, restricted stock units, stock appreciation rights, cash awards, or any combination of the foregoing. As of December 31, 2022, 10.1 million shares were authorized and available for grant under the 2016 Plan. Previously approved plans remain in effect solely for the purpose of governing grants still outstanding that were issued prior to approval of the 2016 Plan. All new grants are issued from the 2016 Plan. In 2018, the Company began issuing cash-settled awards (phantom units) under the restricted stock and conditional restricted stock unit plans. The phantom units represent a hypothetical interest in the Company’s stock and, once vested, are settled in cash. Costs related to the plans are capitalized or expensed to “Lease operating expenses,” “Exploration,” or “General and administrative” in the Company’s statement of consolidated operations based on the nature of each employee’s activities. The following table summarizes the Company’s stock-settled and cash-settled compensation costs:
|  | For the Year Ended December 31,
|  | 2022 |  | 2021 |  | 2020
|  | (In millions)
Stock-settled and cash-settled compensation expensed |  | $ | 304 |  |  | $ | 157 |  |  | $ | 40 |
Stock-settled and cash-settled compensation capitalized |  | 44 |  |  | 18 |  |  | 7 |
Total stock-settled and cash-settled compensation costs |  | $ | 348 |  |  | $ | 175 |  |  | $ | 47 |
Stock Options As of December 31, 2022, the Company had outstanding options to purchase shares of its common stock under the 2016 Plan and the 2011 Omnibus Equity Compensation Plan (the 2011 Plan and, with the 2016 Plan, the Omnibus Plans). The Omnibus Plans were submitted to and approved by the Company’s shareholders. New shares of common stock will be issued for employee stock option exercises. Under the Omnibus Plans, the exercise price of each option equals the closing price of APA’s common stock on the date of grant. Options granted become exercisable ratably over a three-year period and expire 10 years after granted. The following table summarizes stock option activity for the years ended December 31, 2022, 2021, and 2020:
|  | 2022 |  | 2021 |  | 2020
|  | Shares Under Option |  | Weighted Average Exercise Price |  | Shares Under Option |  | Weighted Average Exercise Price |  | Shares Under Option |  | Weighted Average Exercise Price
|  | (In thousands, except exercise price amounts)
Outstanding, beginning of year |  | 3,012 |  |  | $ | 63.79 |  |  | 3,537 |  |  | $ | 72.10 |  |  | 4,298 |  |  | $ | 75.24 |
Exercised |  | (99) |  |  | 42.09 |  |  | — |  |  | — |  |  | — |  |  | — |
Forfeited |  | (2) |  |  | 49.10 |  |  | — |  |  | — |  |  | (37) |  |  | 44.98 |
Expired |  | (833) |  |  | 81.56 |  |  | (525) |  |  | 119.83 |  |  | (724) |  |  | 92.14 |
Outstanding, end of year(1) |  | 2,078 |  |  | 57.71 |  |  | 3,012 |  |  | 63.79 |  |  | 3,537 |  |  | 72.10 |
Expected to vest |  | — |  |  | — |  |  | — |  |  | — |  |  | 150 |  |  | 45.77 |
Exercisable, end of year(1) |  | 2,078 |  |  | 57.71 |  |  | 3,012 |  |  | 63.79 |  |  | 3,387 |  |  | 73.26 |
(1)As of December 31, 2022, options exercisable and outstanding had a weighted average remaining contractual life of 3.1 years and aggregate intrinsic value of $3.5 million. There were no options issued and 98,646 options exercised during the year ended December 31, 2022. There were no options issued and no options exercised during the years ended December 31, 2021, and 2020. Restricted Stock Units and Restricted Stock Phantom Units The Company has restricted stock unit and restricted stock phantom unit plans for eligible employees, including officers. The value of the stock-settled restricted stock unit awards is established by the market price on the date of grant and is recorded as compensation expense ratably over the vesting terms. The restricted stock phantom unit awards represent a hypothetical interest in either the Company’s common stock or, prior to the BCP Business Combination, in ALTM’s common stock, as applicable, and, once vested, are settled in cash. Compensation expense related to the cash-settled awards is recorded as a liability and remeasured at the end of each reporting period over the applicable vesting term. For the years ended December 31, 2022, 2021, and 2020, compensation costs charged to expense for the restricted stock units and restricted stock phantom units was $153 million, $95 million, and $39 million, respectively. As of December 31, 2022, 2021, and 2020, capitalized compensation costs for the restricted stock units and restricted stock phantom units were $22 million, $15 million, and $6 million, respectively. The following table summarizes stock-settled restricted stock unit activity for the years ended December 31, 2022, 2021, and 2020:
|  | 2022 |  | 2021 |  | 2020
|  | Units |  | Weighted Average Grant-Date Fair Value |  | Units |  | Weighted Average Grant-Date Fair Value |  | Units |  | Weighted Average Grant-Date Fair Value
|  | (In thousands, except per share amounts)
Non-vested, beginning of year |  | 2,073 |  |  | $ | 19.98 |  |  | 1,552 |  |  | $ | 28.43 |  |  | 2,448 |  |  | $ | 46.65 |
Granted |  | 847 |  |  | 29.90 |  |  | 1,506 |  |  | 16.46 |  |  | 1,352 |  |  | 24.60 |
Vested(3) |  | (978) |  |  | 22.39 |  |  | (857) |  |  | 29.13 |  |  | (1,933) |  |  | 48.65 |
Forfeited |  | (57) |  |  | 23.49 |  |  | (128) |  |  | 19.78 |  |  | (315) |  |  | 30.09 |
Non-vested, end of year(1)(2) |  | 1,885 |  |  | 23.08 |  |  | 2,073 |  |  | 19.98 |  |  | 1,552 |  |  | 28.43 |
(1)As of December 31, 2022, there was $14 million of total unrecognized compensation cost related to 1,885,491 unvested stock-settled restricted stock units. (2)As of December 31, 2022, the weighted-average remaining life of unvested stock-settled restricted stock units is approximately 0.7 years. (3)The grant date fair values of the stock-settled awards vested during 2022, 2021, and 2020 were approximately $22 million, $25 million, and $94 million, respectively. The following table summarizes cash-settled restricted stock phantom unit activity for the years ended December 31, 2022, 2021, and 2020:
|  | For the Year Ended December 31,
|  | 2022 |  | 2021 |  | 2020
|  | (In thousands)
Non-vested, beginning of year |  | 6,402 |  |  | 4,423 |  |  | 5,384 |
Adjustment for ALTM reverse stock split(1) |  | — |  |  | — |  |  | (1,246) |
Adjustment from ALTM transaction(2) |  | 143 |  |  | — |  |  | — |
Granted(3) |  | 2,568 |  |  | 4,441 |  |  | 3,462 |
Vested |  | (2,970) |  |  | (2,049) |  |  | (1,618) |
Forfeited |  | (434) |  |  | (413) |  |  | (1,559) |
Non-vested, end of year(4) |  | 5,709 |  |  | 6,402 |  |  | 4,423 |
(1)Prior to the deconsolidation of Altus on February 22, 2022, on June 30, 2020, ALTM executed a 1-for-20 reverse stock split of its outstanding common stock. Outstanding cash-settled awards were based on the per-share market price of ALTM common stock. (2)Following the BCP Business Combination, certain employees were granted restricted stock phantom units based on APA’s common stock price to replace the equivalent value in restricted stock phantom units based on ALTM’s common stock price. (3)Restricted stock phantom units granted during 2022, 2021, and 2020 included 2,512,602, 4,375,546, and 3,378,486 awards, respectively, based on the per-share market price of APA common stock and 55,546, 65,327, and 83,239 awards, respectively, based on the per-share market price of ALTM common stock prior to the deconsolidation of Altus on February 22, 2022. The restricted stock phantom units granted during 2020 based on ALTM’s per-share market price reflect the 1-for-20 reverse stock split described above. (4)The outstanding liability for the unvested cash-settled restricted stock phantom units that had not been recognized as of December 31, 2022 was approximately $103 million. In January 2023, the Company awarded 580,254 restricted stock units and 1,950,332 restricted stock phantom units based on APA’s weighted-average per-share market price of $42.15 under the 2016 Plan to eligible employees. Total compensation cost for the restricted stock units and the restricted stock phantom units, absent any forfeitures, is estimated to be $24 million and $85 million, respectively, and was calculated based on the per-share fair market value of a share of the Company’s common stock as of the grant date. Compensation cost will be recognized over a three-year vesting period for both plans. The restricted stock phantom units will be classified as a liability and remeasured at the end of each reporting period based on the change in fair value of one share of the Company’s common stock, a Level 1 fair value measurement. Performance Program To provide long-term incentives for the Company’s employees to deliver competitive shareholder returns, the Company makes annual grants of conditional restricted stock units to eligible employees. APA has a performance program for certain eligible employees with payout for a portion of the shares based upon measurement of total shareholder return (TSR) of APA common stock as compared to a designated peer group during a three-year performance period. Payout for the remaining portion of the shares is based on performance and financial objectives as defined in the plan. The overall results of the objectives are calculated at the end of the award’s stated performance period and, if a payout is warranted, applied to the target number of restricted stock units awarded. The performance shares will immediately vest 50 percent at the end of the three-year performance period, with the remaining 50 percent vesting at the end of the following year. Grants from the performance programs outstanding at December 31, 2022, are as described below: •In January 2018, the Company’s Board of Directors approved the 2018 Performance Program, pursuant to the 2016 Plan. Eligible employees received initial cash-settled conditional phantom units totaling 931,049 units. A total of 23,633 phantom units were outstanding as of December 31, 2022. The results for the performance period yielded a payout of 23 percent of target. •In January 2019, the Company’s Board of Directors approved the 2019 Performance Program, pursuant to the 2016 Plan. Eligible employees received initial cash-settled conditional phantom units totaling 1,679,832 units. A total of 604,417 phantom units were outstanding as of December 31, 2022. The results for the performance period yielded a payout of 100 percent of target. •In January 2020, the Company’s Board of Directors approved the 2020 Performance Program, pursuant to the 2016 Plan. Eligible employees received initial cash-settled conditional phantom units totaling 1,687,307 units. A total of 1,311,715 phantom units were outstanding as of December 31, 2022. The results for the performance period yielded a payout of 155 percent of target. •In January 2021, the Company’s Board of Directors approved the 2021 Performance Program, pursuant to the 2016 Plan. Eligible employees received the initial cash-settled conditional phantom units totaling 1,959,856 units. The actual amount of phantom units awarded will be between zero and 200 percent of target. A total of 1,826,890 phantom units were outstanding as of December 31, 2022, from which a minimum of zero to a maximum of 3,653,780 units could be awarded. •In January 2022, the Company’s Board of Directors approved the 2022 Performance Program, pursuant to the 2016 Plan. Eligible employees received the initial cash-settled conditional phantom units totaling 1,093,034 units. The actual amount of phantom units awarded will be between zero and 200 percent of target. A total of 1,068,530 phantom units were outstanding as of December 31, 2022, from which a minimum of zero to a maximum of 2,137,060 units could be awarded. Compensation costs charged to expense under the performance programs were an expense of $143 million, an expense of $57 million, and a credit of $8 million during 2022, 2021, and 2020, respectively. Capitalized compensation costs under the performance programs were an expense of $21 million, an expense of $3 million, and a credit of $1 million during 2022, 2021, and 2020, respectively. The following table summarizes cash-settled conditional restricted stock unit activity for the year ended December 31, 2022:
|  | Units
|  | (In thousands)
Non-vested, beginning of year |  | 4,531 |
Granted |  | 1,676 |
Vested |  | (656) |
Forfeited |  | (106) |
Expired |  | (610) |
Non-vested, end of year(1) |  | 4,835 |
(1)As of December 31, 2022, the outstanding liability for the unvested cash-settled conditional restricted stock units that had not been recognized was approximately $53 million. In January 2023, the Company’s board of directors approved the 2023 Performance Program, pursuant to the 2016 Plan. Payout for 40 percent of the shares is based upon measurement of TSR of APA common stock as compared to a designated peer group and the S&P 500 Index during a three-year performance period. Payout for the remaining 60 percent of the shares is based on the performance and financial objectives defined in the 2023 Performance Program. Eligible employees received the initial cash-settled conditional phantom units totaling 797,429 units, with the ultimate number of phantom units to be awarded ranging from zero to a maximum of 1,594,858 units. These phantom units represent a hypothetical interest in the Company’s common stock, and, once vested, are settled in cash. The TSR component of the award had a grant date fair value per award of $62.15 based on a Monte Carlo simulation. The grant date fair value per award for the remaining 60 percent was $44.06 based on the weighted-average fair market value of a share of common stock of the Company as of the grant date. These 2023 Performance Program phantom units will be classified as a liability and remeasured at the end of each reporting period based on the change in fair value of one share of the Company’s common stock, a Level 1 fair value measurement.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI https://asc.fasb.org/topic&trid=2208762 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (h) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 16 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (i) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 6 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration